Biopharma Updates: Sumitomo Surges on US Sales While INmune Bio Pushes Cancer Pipeline
Sumitomo Pharma is feeling pretty optimistic about its recently ended fiscal year. Riding a wave of strong North American sales,...
Sumitomo Pharma is feeling pretty optimistic about its recently ended fiscal year. Riding a wave of strong North American sales,...